Emerging Manager in Private Equity: Evaluating First-Time Funds
An emerging manager in private equity is a firm launching its first, second or third fund, judged on its team's attributable prior work because it has little fund-level record.
Reviewed by José Vasquéz, Managing Partner · Last reviewed
Mechanism
Allocators cannot rely on fund-level performance for a new firm, so they rebuild a track record from the team's earlier work. The question is attribution: which investments did these named people originate, lead and exit, and what part of the result belonged to them and not to the employer? A partner who sat on a deal team as the fourth person did not produce the same evidence as one who sourced the investment and held the board seat.
Rebuilding evidence follows four steps.
- List every deal the principals touched, with their role, the entry and exit dates, invested capital and proceeds.
- Weight by role: lead, co-lead, supporting or observer. Give lead roles full credit and supporting roles partial credit.
- Check the strategy match: sector, stage, check size and geography of past deals against the new fund's plan.
- Test the references: speak to former colleagues, co-investors, management teams and any lender.
The ILPA Due Diligence Questionnaire 2.0 asks for predecessor-fund performance and, for each lead deal team member, the cash flows of deals completed before joining or forming the general partner. Program definitions and thresholds, such as how public pension plans define an emerging manager, are covered in Emerging Manager.
Worked Example
Consider a hypothetical team of two partners launching a first fund. Between them they were involved in six investments at a prior firm. The table shows invested capital, proceeds and each partner's credited share. Credit is a diligence judgment, not an industry standard: lead roles receive 100 percent, co-lead 50 percent, supporting 25 percent.
| Deal | Role | Invested | Proceeds | Multiple | Credit |
|---|---|---|---|---|---|
| A | Lead | $20,000,000 | $60,000,000 | 3.0x | 100 percent |
| B | Lead | $15,000,000 | $12,000,000 | 0.8x | 100 percent |
| C | Co-lead | $25,000,000 | $50,000,000 | 2.0x | 50 percent |
| D | Supporting | $30,000,000 | $75,000,000 | 2.5x | 25 percent |
| E | Supporting | $30,000,000 | $21,000,000 | 0.7x | 25 percent |
| F | Lead | $10,000,000 | $15,000,000 | 1.5x | 100 percent |
All six deals together invested $130,000,000 and returned $233,000,000, a blended 1.79x. That figure flatters the team, because it counts deals where the partners had small roles. Weighting capital by credit gives credited invested capital of $20,000,000 + $15,000,000 + $12,500,000 + $7,500,000 + $7,500,000 + $10,000,000 = $72,500,000. Credited proceeds are $60,000,000 + $12,000,000 + $25,000,000 + $18,750,000 + $5,250,000 + $15,000,000 = $136,000,000. The credited multiple is $136,000,000 divided by $72,500,000, or 1.88x. Looking only at the three deals the partners led, the multiple is $87,000,000 divided by $45,000,000, or 1.93x, with one of the three below cost. The sample is small, so an allocator should read it as evidence about judgment and loss ratio, not as a forecast.
Terms and Alignment for an Emerging Manager in Private Equity
Terms matter more when the record is thin. The ILPA Principles 3.0 ask for a substantial cash general partner interest, fee levels tied to the cost of running the fund and a key person provision naming the people who decide investments. First-time managers often offer a lower fee, a stronger preferred return or a founders' discount to early investors. An allocator should compare each concession with what it buys; a discount is not a substitute for attribution. See GP Commitment and Key Person Provision for how those terms work.
What It Means for a Limited Partner
Backing an emerging manager is a bet on a team, and persistence research supports looking carefully at who the team is. Kaplan and Schoar, in Private Equity Performance: Returns, Persistence and Capital Flows, found that a partnership's results in one fund relate to its results in the next. Harris and co-authors, in Has Persistence Persisted in Private Equity?, found that venture capital persistence holds even when measured on the information an investor has at fundraising, while buyout persistence largely disappears on that measure. For a limited partner, the lesson is that a record belongs to people, and persistence is not a guarantee. A disciplined allocator sizes a first-time commitment so that one weak manager does not matter to the whole portfolio, tracks the team over time and reviews operations as carefully as for an established firm; see Operational Due Diligence in Private Equity. Many allocators also reserve capital for the manager's second fund, so a successful relationship can grow.
In Life Sciences and Healthcare
Attribution is harder in life sciences because outcomes depend on science and regulation. A partner who led a financing before a failed trial did not cause the failure, and a partner who sat on the board of a successful device company may have contributed little to the approval. Reviewers should ask what the person decided: the target, the milestone structure, the follow-on reserve or the exit route. They should also ask whether the team has medical, scientific or regulatory depth in the sector the new fund targets, and who outside the firm can confirm it.
Frequently Asked Questions
What is an emerging manager in private equity?
It is a firm launching an early fund, usually its first through third, without a long fund-level record. Definitions differ by investor, and many public pension programs use fund size or years in business as well. Allocators judge such a firm on the team's attributable prior deals, references and terms. Program thresholds are described in Emerging Manager.
How do allocators measure a first-time team's track record?
They rebuild it deal by deal: each investment, the person's role, invested capital, proceeds and dates. Lead roles receive more credit than supporting ones. The credited multiple and loss ratio are then compared with the stated strategy. References from co-investors and management teams test whether the claimed role was real.
Do emerging managers outperform established ones?
No single answer holds across eras, strategies and data sets, and this entry does not claim one. Persistence research suggests that a record attached to named people is informative, but also that, judged on the information available at fundraising, persistence holds in venture capital and largely disappears in buyout. Allocators should treat each manager on its own evidence and size commitments for the risk of a wrong call.
Related Reference
New-manager selection is part of the growth equity allocator's job. Related entries: Emerging Manager, GP Commitment and Key Person Provision.